Skip to main content

Table 1 Patient and adrenal metastasis characteristics

From: Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience

Characteristics

Value (n = 22)

Patient characteristics

Sex

 Male

21

 Female

1

Age, yeara

52 (33–75)

Hepatitis

 Yes

19

 No

3

Previous HCC treatment

 Resection

17

 Transplantation

3

 Ablation

2

AFP (μg/L)

  ≤ 400

15

  > 400

7

Cirrhosis

 Yes

10

 No

12

Child-Pugh class

 A

19

 B

3

ECOG Performance Status

 0

20

 1

2

Tumour characteristics

Time to adrenal metastases

 Synchronous (≤ 6 months)

6

 Metachronous (>  6 months)

16

Extent of disease at time of ablation

 Isolated AM

11

 rHCC and AM

9

 Metastases in other sites

2

Tumour size

  ≤ 5 cm

17

  > 5 cm

5

Laterality

 Right

20

 Left

2

  1. amedian (range), HCC hepatocellular carcinoma, AFP alpha-fetoprotein, ECOG Eastern Cooperative Oncology Group, AM adrenal metastasis, rHCC recurrent hepatocellular carcinoma